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Abstract
Background Although low child and adult grip strength is associated with adverse cardiometabolic health, how grip strength 
across the life course associates with type 2 diabetes is unknown. This study identified the relative contribution of grip 
strength measured at specific life stages (childhood, young adulthood, mid-adulthood) with prediabetes or type 2 diabetes 
in mid-adulthood.
Methods Between 1985 and 2019, 263 participants had their grip strength measured using an isometric dynamometer in 
childhood (9–15 years), young adulthood (28–36 years) and mid-adulthood (38–49 years). In mid-adulthood, a fasting blood 
sample was collected and tested for glucose and glycated haemoglobin (HbA1c). Participants were categorized as having 
prediabetes or type 2 diabetes if fasting glucose levels were ≥ 5.6 mmol or if HbA1c levels were ≥ 5.7% (≥ 39 mmol/mol). 
A Bayesian relevant life course exposure model examined the association between lifelong grip strength and prediabetes or 
type 2 diabetes.
Results Grip strength at each time point was equally associated with prediabetes or type 2 diabetes in mid-adulthood (child-
hood: 37%, young adulthood: 36%, mid-adulthood: 28%). A one standard deviation increase in cumulative grip strength 
was associated with 34% reduced odds of prediabetes or type 2 diabetes in mid-adulthood (OR 0.66, 95% credible interval 
0.40, 0.98).
Conclusions Greater grip strength across the life course could protect against the development of prediabetes and type 2 
diabetes. Strategies aimed at increasing muscular strength in childhood and maintaining behaviours to improve strength into 
adulthood could improve future cardiometabolic health.
Leigh Blizzard and Marie-Jeanne Buscot contributed equally to 
this work and are considered equal second authors.
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1  Background
As the prevalence of type 2 diabetes and its precursor 
state of prediabetes increases [1], risk reduction strate-
gies to prevent the development of this chronic disease are 
critical. A recent systematic review and meta-analysis of 
observational research presented in adults suggested that 
a one standard deviation increase in muscular strength is 
associated with a 13% lower risk of type 2 diabetes [2]. This 
finding is supported by a Mendelian randomization study 
that showed SNPs associated with higher grip strength, a 
proxy of muscular strength, to associate with lower odds 
of type 2 diabetes [3]. However, the link between muscular 
strength and impaired glucose homeostasis, a risk factor for 
type 2 diabetes, is not limited to adults. Greater childhood 
muscular strength is associated with lower levels of insulin 
resistance and beta cell function in adulthood [4, 5], while 
findings from a Swedish cohort of male military conscripts 
showed low muscular strength measured at age 18 years 
to associate with a 52% increased risk of type 2 diabetes 
10–40 years later [6]. These findings suggest childhood mus-
cular strength, often measured as grip strength, could be a 
potential early life target for strategies aimed at preventing 
type 2 diabetes in adulthood. However, previous observa-
tional studies have been limited to two time point analyses 
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Key Points 
This study is the first to use a life course model to 
identify the relative contribution of muscular strength 
measured at different stages across the life course to the 
development of type 2 diabetes in mid-adulthood. We 
found that muscular strength measured in childhood, 
young- and mid-adulthood was equally associated with 
prediabetes or type 2 diabetes in mid-adulthood.
These findings emphasize the importance of a life course 
approach to the prevention of type 2 diabetes and suggest 
that the health benefits of people of all ages participat-
ing in muscle-strengthening activities should be better 
promoted.
Strategies aimed at increasing muscular strength in 
childhood and maintaining behaviours to increase mus-
cular strength into later life could be encouraged to help 
prevent the development of type 2 diabetes.
and Fitness Survey (ASHFS) and had their health and fitness 
assessed [8]. A subset of children aged 9, 12 and 15 years 
had their grip strength measured. Participants were followed 
up and attended clinics as part of the Childhood Determi-
nants of Adult Health (CDAH) Study in 2004–06 when aged 
28–36 years (young adulthood) and in 2014–19 when aged 
38–49 years (mid-adulthood). During these adult follow-ups, 
participants had their grip strength reassessed and provided a 
fasting blood sample that was tested for glucose and glycated 
haemoglobin (HbA1c). Included in analyses were 263 par-
ticipants who had their grip strength measured in childhood, 
young- and mid-adulthood and who provided a fasting blood 
sample in mid-adulthood, did not have type 1 diabetes and 
were not pregnant. A flowchart of participation is presented 
in Fig. 1. The ASHFS was approved by the State Directors 
General of Education. Follow-up studies were approved by 
the Southern Tasmania Health and Medical Human Research 
Ethics Committee and the Tasmania Health and Medical 
Human Research Ethics Committee. All participants pro-
vided written informed consent.
2.2  Grip Strength Across the Life Course
In childhood, young- and mid-adulthood, right and left grip 
strength was measured by maximum voluntary contraction 
using an isometric dynamometer (Smedley’s Dynamometer, 
TTM, Tokyo, Japan) that was adjusted to fit the size of the 
participant’s hand. Grip strength was measured by partici-
pants gripping the dynamometer with maximum force with 
one hand, whilst the dynamometer rested on the opposite 
shoulder. In childhood, participants had one attempt at right 
and left grip strength. In adulthood, the maximum of two 
attempts was used in analyses. At each time point, partici-
pants reported whether their dominant hand was right or 
left. To remove the influence of body mass on grip strength 
performance, dominant grip strength not attributable to 
body mass at all three life stages was created by regressing 
dominant grip strength on body mass and using the residu-
als added to the grand mean [9], and standardized for age 
and sex.
2.3  Anthropometric Measures
Regularly calibrated scales measured body mass to the 
nearest 0.5 kg in childhood and Heine scales (Heine, Dover, 
NH) measured body mass to the nearest 0.1 kg in adult-
hood. Height was measured to the closest 0.1 cm using a 
KaWe height tape (KaWe Kirchner & Wilhelm, Aspeg, Ger-
many) in childhood and a Leicester height measure (Invicta, 
Leicester, UK) in adulthood. BMI was calculated as body 
mass (kg) divided by height (m) squared. Using a constant 
tension tape, child waist circumference was measured to 
the nearest 0.1 cm at the level of the umbilicus and adult 
or had muscular strength data available only at baseline. It 
is currently unknown how grip strength measured across the 
life course is associated with type 2 diabetes.
Examining how grip strength associates with prediabe-
tes or type 2 diabetes using life course approaches could 
inform future prevention strategies [7]. This association 
may be reflected by a critical period model, where grip 
strength at only one life stage is important for prediabetes 
or type 2 diabetes risk; a sensitive period model, where grip 
strength measured at one or more life stages has a greater 
effect on prediabetes or type 2 diabetes risk compared 
with grip strength at other life stages; or an accumulation 
model, where grip strength measured across the life course 
is equally important for the development of prediabetes or 
type 2 diabetes [7]. The pattern by which life course grip 
strength is associated with type 2 diabetes could provide 
insight into when interventions aimed at preventing type 2 
diabetes by targeting muscular strength levels could be most 
effectively implemented.
This study aimed to identify the life course model that 
best describes the association between grip strength meas-
ured in childhood, young adulthood and mid-adulthood and 
the risk of prediabetes or type 2 diabetes in mid-adulthood.
2  Research Design and Methods
2.1  Participants
In 1985, a nationally representative sample of Australian 
schoolchildren participated in the Australian Schools Health 
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waist circumference was measured at the narrowest point 
between the lower costal border and the iliac crest. Triceps, 
biceps, subscapular, and suprailiac skinfolds were measured 
using Holtain calipers (Holtain, Crymych, UK) to the nearest 
0.2 mm in childhood and using Slim Guide Calipers to the 
nearest 0.5 mm in adulthood. Using the log of sum of four 
skinfolds, body density and fat percentage were calculated 
according to age-specific regression estimates [10]. Using 
the Siri formula, body fat was calculated from body density 
[11]. The difference between total body mass and fat mass 
was used to estimate fat-free mass.
2.4  Cardiorespiratory Fitness
Cardiorespiratory fitness (CRF) was estimated as physical 
work capacity at 170 beats per minute  (PWC170) using a 
Monark 818E bicycle ergometer (Monark Exercise AB, 
Vansbro, Sweden) in childhood, a Monark 828E bicycle 
ergometer (Monark Exercise AB, Vansbro, Sweden) in 
young adulthood and a Monark 928G3r bicycle ergometer 
(Monark Exercise AB, Vansbro, Sweden) in mid-adulthood. 
Participants pedalled at a cadence of 60 RPM and the test 
included three 3-min workloads (childhood) or three 4-min 
workloads (adulthood) that increased resistance stepwise. 
In the final minute of each workload, watts and heart rate 
were measured, and the regression lines were extrapolated to 
estimate  PWC170. To remove the influence of muscle mass, 
measures of  PWC170 not attributable to fat-free mass were 
created by regressing  PWC170 on fat-free mass and using the 
residuals added to the grand mean.
2.5  Prediabetes and Type 2 Diabetes
In mid-adulthood, participants provided a blood sample that 
was tested for glucose using a Siemens Advia 2400 Chem-
istry analyzer (Siemens Healthcare Diagnostics Inc., Deer-
field, IL, USA) and HbA1c using a Bio-Rad D100 HbA1c 
analyzer (Bio-Rad Laboratories Inc., Hercules, CA, USA). 
A fasting status of ≥ 8 h was confirmed with the participant 
upon clinic arrival. Participants were categorized as having 
prediabetes or type 2 diabetes if they self-reported having 
type 2 diabetes or being on medication for type 2 diabetes, 
or if their fasting glucose levels were ≥ 5.6 mmol/L and/or 
HbA1c levels were ≥ 5.7% (≥ 39 mmol/mol), as defined by 
the American Diabetes Association [12].
2.6  Statistical Analyses
2.6.1  Demographics
Participant characteristics were examined using Stata (Ver-
sion 15.0, StataCorp, College Station, Texas). For continu-
ous variables, mean and standard deviation (SD) are pre-
sented. For categorical variables, percentage and number of 
participants are reported.
Fig. 1  Flow chart of participation. ASHFS Australian Schools Health and Fitness Survey, CDAH Childhood Determinants of Adult Health, 
HbA1c glycated haemoglobin
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2.6.2  Bayesian Model for Life Course Investigation
In R (Version 3.5.3, R Foundation for Statistical Computing, 
Vienna, Austria) [13] using the Stan package to fit Bayes-
ian models [14], the Bayesian relevant life course exposure 
model (BRLM) was used to identify the relative importance 
of grip strength measured in childhood, young adulthood 
and mid-adulthood on prediabetes or type 2 diabetes in 
mid-adulthood [15, 16]. Full methodological detail outlin-
ing the BRLM has been published previously [15, 16] and 
is summarized in the supplementary material. Briefly, the 
relative importance of grip strength at each period to the 
development of prediabetes or type 2 diabetes is assumed 
by weights (childhood = W1, young adulthood = W2, mid-
adulthood = W3), allowing grip strength to associate with 
prediabetes or type 2 diabetes at different levels depend-
ing on the life stage at which it was measured. The relative 
weights and the joint posterior distribution of the weight 
parameters at each of the three life stages, visualized using 
a ternary plot, help determine the life course model best 
supported by the data. When the posterior distribution of 
weights cluster along vertices of the ternary plot, the model 
indicates critical periods for the corresponding life stage, 
and when the posterior distribution clusters in the central 
area of the plot, the model suggests an accumulation model 
[15, 16]. The BRLM also estimates an overall effect for the 
lifetime exposure of grip strength, representing the maxi-
mum accumulated effect of grip strength across the life 
course on prediabetes or type 2 diabetes, and derives life 
stage-specific effects (a combination of the overall effect and 
relative weights), representing the time-dependent associa-
tion between grip strength and prediabetes or type 2 diabetes 
[15, 16]. Posterior distributions were used to compute mean 
and 95% credible intervals (95% CrI) for weights (inter-
preted as relative importance) and odds ratios (OR) for the 
overall effect.
In a sensitivity analysis, lifetime average standardized 
values of CRF and waist circumference were included as 
covariates. These covariates were derived by age- and sex-
standardizing CRF and waist circumference in childhood, 
young- and mid-adulthood and creating a numerical average 
from across the life course.
3  Results
3.1  Demographics
Participant characteristics are presented in Table 1. The 
average length of follow-up between childhood and mid-
adulthood was 32.5 (1.1) years. Dominant grip strength and 
 PWC170 were greatest in young adulthood. Body mass, waist 
circumference and fat-free mass increased with increasing 
age. Of the 263 participants, 48.3% (n = 127) were male 
and 7.2% (n = 19) had prediabetes or type 2 diabetes in 
mid-adulthood.
3.2  Bayesian Model for Life Course Investigation
The unadjusted association between life course grip strength 
and prediabetes or type 2 diabetes in mid-adulthood is pre-
sented in Table 2. As reflected by the lifetime effect, a one 
SD increase in life course cumulative grip strength was asso-
ciated with 34% reduced odds of prediabetes or type 2 dia-
betes in mid-adulthood (OR 0.66, 95% CI 0.40, 0.98). Con-
tributing to this lifetime effect was grip strength measured in 
childhood, young- and mid-adulthood. The relative impor-
tance of grip strength measured at each of these life stages 
in relation to the odds of developing prediabetes or type 2 
diabetes in mid-adulthood was approximately equal (ranging 
from 28 to 37%; Table 2 and Fig. 2), although the posterior 
(Fig. 2) and prior distributions (Figure S1) overlapped. As 
the relative importance values (i.e. weights) were not exactly 
equal, the association between life course grip strength and 
prediabetes or type 2 diabetes was suggestive of a relaxed 
accumulation life course model (W1 ≈ W2 ≈ W3) compared 
with a pure accumulation model (W1 = W2 = W3). The life 
stage-specific effects, derived as the product of the lifetime 
effect and life stage-specific relative weights, presented in 
Fig. 3 support this interpretation. A one SD increase in grip 
strength at each examined life stage was similarly associated 
with prediabetes or type 2 diabetes in mid-adulthood.
When life course CRF and waist circumference were 
included in the model as covariates, evidence for a relaxed 
accumulation model persisted, with the relative importance 
of grip strength at each life stage remaining essentially 
unchanged (Table S1). The lifetime effect and each life 
stage-specific effect attenuated, and statistical significance 
was lost, although the effects remained in a protective direc-
tion (Tables S1 and S2).
4  Discussion
This study is the first to identify the relative contribution of 
grip strength measured across the life course with prediabe-
tes or type 2 diabetes in mid-adulthood. Our estimates sug-
gest an approximately equal contribution from grip strength 
measured in childhood, young adulthood and mid-adulthood 
on prediabetes or type 2 diabetes risk and that greater cumu-
lative grip strength across the life course was associated with 
a 34% reduction in the odds of developing prediabetes or 
type 2 diabetes in mid-adulthood. These findings are consist-
ent with recent confirmation of a causal link between grip 
strength and type 2 diabetes from Mendelian randomization 
analysis [3] by demonstrating the cumulative nature of the 
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association across the life course. As such, our data support 
the importance of developing and maintaining higher levels 
of muscular strength beginning in childhood and continuing 
through mid-adulthood to maximize future cardiometabolic 
health benefits.
Despite this being the first study to apply a life course 
modelling framework to examine the association of grip 
strength with prediabetes or type 2 diabetes, previous work 
provides a strong rationale for a causal link. For example, a 
recent two-sample Mendelian randomization study [3] that 
applied SNPs associated with grip strength obtained from 
the UK Biobank to data from two large meta-analysis con-
sortia of type 2 diabetes and glycaemic traits (DIAGRAM 
and MAGIC) found a one SD increase in grip strength was 
associated with 23% lower odds of type 2 diabetes (OR 0.77, 
95% CI 0.62, 0.95) [3]. The association between measures of 
muscular strength and type 2 diabetes risk is also supported 
by observational data. Results from a systematic review and 
meta-analysis suggest that in adulthood, a one SD increase in 
muscular strength is associated with a 13% decreased risk of 
type 2 diabetes (RR 0.87, 95% CI 0.81, 0.94), independent 
of BMI or waist to hip ratio [2]. The longitudinal association 
between child and adolescent muscular strength with adult 
type 2 diabetes and associated risk factors has also been 
described, independent of CRF and waist circumference. 
Higher levels of childhood muscular strength were associ-
ated with lower adult levels of insulin resistance and beta 
cell function, precursors of type 2 diabetes, among cohorts 
from Australia and Europe [4, 5], while low levels of mus-
cular strength among Swedish male military conscripts aged 
18 years were associated with an increased risk of type 2 
diabetes 10–40 years later, independent of CRF and BMI [6].
Our findings expand current evidence by suggesting grip 
strength measured at three life stages were similarly associ-
ated with prediabetes or type 2 diabetes in mid-adulthood. 
Consequently, childhood, young adulthood and mid-adult-
hood are equally important life stages that can be targeted 
to help protect against the development of type 2 diabetes. 
Table 1  Characteristics of participants
*Mean (standard deviation) for continuous variables and percentage (number of participants) for categorical variables
HbA1c glycated haemoglobin, PWC170 physical work capacity at 170 beats per minute
Characteristic Childhood Young adulthood Mid-adulthood
n Statistic* n Statistic* n Statistic*
Age (years) 263 11.7 (2.4) 263 31.6 (2.5) 263 44.2 (2.7)
Right grip strength (kg) 263 22.6 (8.6) 263 38.6 (10.4) 263 38.4 (10.7)
Left grip strength (kg) 263 22.0 (8.6) 262 36.7 (10.7) 263 36.4 (10.8)
Dominant grip strength (kg) 263 22.7 (8.6) 263 38.7 (10.6) 263 38.2 (10.7)
Dominant grip strength not attributable to body mass (kg) 263 23.0 (8.1) 263 39.0 (10.5) 263 38.2 (10.6)
Age- and sex-standardized dominant grip strength not attribut-
able to body mass
263 0.08 (1.00) 263 0.05 (1.00) 263 –0.01 (1.07)
Body mass (kg) 263 41.9 (12.7) 263 74.8 (14.8) 263 80.0 (17.4)
Waist circumference (cm) 263 63.4 (7.4) 249 82.1 (10.6) 263 87.0 (12.3)
Body mass index (kg/m2) 263 18.2 (2.7) 262 24.9 (3.8) 263 26.8 (4.9)
Fat-free mass (kg) 263 32.8 (8.9) 248 53.9 (11.4) 260 55.2 (11.3)
PWC170 (W) 250 91.1 (35.9) 248 165.5 (50.1) 185 145.7 (66.8)
PWC170 not attributable to fat-free mass (W) 250 91.6 (32.6) 244 168.0 (47.1) 182 146.4 (65.7)
Fasting glucose (mmol/L) 257 4.7 (0.5)
HbA1c (%) 263 5.2 (0.3)
Prediabetes or type 2 diabetes 263
 No 92.8% (244)
 Yes 7.2% (19)
Table 2  Association between dominant grip strength and prediabetes 
or type 2 diabetes
CrI credible intervals
Odds ratio (95% CrI) Relative 
importance 
(95% CrI)
Prediabetes or type 2 dia-
betes
Lifetime effect 0.66 (0.40, 0.98)
Life stages
 Childhood 37% (4%, 78%)
 Young adulthood 36% (3%, 78%)
 Mid-adulthood 28% (2%, 69%)
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That is, it is not grip strength at a single period in the life 
course or the tracking of grip strength from distal to proxi-
mal time points that explains the association with type 2 
diabetes. These results suggest that greater cumulative grip 
strength across the life course is important in preventing 
prediabetes and type 2 diabetes. These findings support cur-
rent national and global physical activity guidelines where 
both children and adults are encouraged to participate in 
muscle-strengthening activities [17, 18]. Strategies aimed 
at promoting environments and factors leading to muscular 
strength gains in childhood and initiating and maintaining 
participation in muscle-strengthening activities into adult-
hood could help prevent the development of type 2 dia-
betes. Evidence suggests resistance training interventions 
administered in schools can increase childhood muscular 
fitness levels [19]. Furthermore, the modifiable factors of 
lower adiposity and higher fat-free mass, CRF, flexibility, 
and speed capability could be targeted for strategies aimed 
at increasing childhood muscular strength [20]. Of concern, 
childhood muscular fitness levels have declined over time 
[21], and as muscular strength tracks between childhood and 
adulthood [22], this decline could have long-term effects 
on future muscular strength. Therefore, implementing well-
informed strategies aimed at improving muscular strength in 
childhood are required to help promote favourable muscular 
strength levels across the life course.
The mechanism explaining the association between grip 
strength and type 2 diabetes is unknown. Associations may 
be acting indirectly through adiposity levels. However, grip 
strength appears to associate with type 2 diabetes independ-
ent of adiposity levels. The direct association between grip 
strength and type 2 diabetes could be explained by resist-
ance training-induced improvements in glucose homeostasis, 
whereby resistance training lowers HbA1c levels [23, 24] 
and upregulates key proteins in the insulin signalling cas-
cade [25]. Given grip strength is a measure of overall muscu-
lar strength [26] and resistance training increases muscular 
strength levels [27, 28], the glucose homeostasis benefits of 
resistance training are likely to explain the observed asso-
ciation. However, whether the link between behaviours that 
increase muscular strength and type 2 diabetes explain the 
relaxed accumulation model highlighted in this study is 
unknown. Genetic factors or the persistence of higher levels 
of fat-free mass and protective innate muscle traits, such as 
mitochondrial density, intramuscular fat and skeletal muscle 
fibre type, across the life course could be responsible for the 
accumulative effect of muscle strength on type 2 diabetes 
risk. Although additional research is required to confirm the 
exact mechanisms, results from this study suggest protective 
effects begin in childhood and that greater cumulative grip 
strength across the life course is beneficial. These data rein-
force the causal link between grip strength and type 2 dia-
betes highlighted by Mendelian randomization analysis [3].
This study had limitations. Due to time and economic 
constraints at baseline, a subset of children had grip strength 
measured. For inclusion in our analysis dataset, those with 
Fig. 2  Posterior joint distribution of weights estimated for dominant 
grip strength measured in childhood, young adulthood and mid-
adulthood with 50% (thick solid line) and 95% (dashed line) credible 
intervals. The solid lines represent the mean posterior probability of 
the weights. Darker areas represent a higher density of posterior mean 
estimates of the weights. The location of the posterior joint distribu-
tion of weights highlights the life course model best supported by the 
data. For example, in a critical period model the highest density of 
posterior mean estimates of the weights would lie along one of the 
vertices (W1 = childhood critical period; W2 = young adulthood criti-
cal period; W3 = mid-adulthood critical period); in an accumulation 
model, the highest density of posterior mean estimates of the weights 
would be around the central point; and in a sensitive period model 
the highest density of posterior mean estimates of the weights would 
be between the vertices and the central point. W1 posterior mean 
estimates of weights for childhood, W2 posterior mean estimates of 
weights for young adulthood, W3 posterior mean estimates of weights 
for mid-adulthood
Fig. 3  Life stage-specific associations between dominant grip 
strength and prediabetes or type 2 diabetes. CrI credible intervals
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grip strength measured at baseline had to attend and pass fit-
ness exclusion questionnaires at both follow-ups. A substan-
tial proportion did not fulfil all participation requirements, 
resulting in a relatively small sample size and case numbers 
for analysis. Nevertheless, our simulation study showed that 
we had > 80% power to detect the true life course model in 
a sample of this size given the prevalence of type 2 diabetes 
(see supplementary material). Whilst we cannot discount 
participation bias, it is reassuring that participants and non-
participants were similar in baseline characteristics, and 
that for the two characteristics (socioeconomic status and 
smoking status) in which there were differences, the strength 
of the inverse relationship between baseline grip strength 
and prediabetes or type 2 diabetes for non-participants at 
follow-up was close to uniform in each category of socioeco-
nomic status and smoking status. In all categories of socio-
economic status and for the large group of non-smokers, 
our estimate of the inverse relationship between baseline 
grip strength and risk of prediabetes or type 2 diabetes was 
stronger (further from the null) for non-participants than for 
participants. This raises the possibility that the protective 
effect of grip strength has been underestimated in this study 
(any bias is towards the null). Furthermore, given our low 
sample size, the posterior (Fig. 2) and prior distributions 
(Figure S1) overlapped and credible intervals were wide. We 
recommend that the research be replicated in other cohorts 
with larger sample sizes to see if findings are consistent. 
Furthermore, the newly developed BRLM approach does 
not currently allow inclusion of time varying covariates. In 
our study, it was important to attempt to remove the influ-
ence of CRF and waist circumference from the association 
between life course grip strength and prediabetes or type 2 
diabetes. In the absence of a formal method incorporated 
within the BRLM, we included an average life course stand-
ardized value of CRF and waist circumference in the model. 
Although this approach is not ideal as it considers a cumula-
tive effect averaged from one to three time points, this was 
the best approach available to us. Strengths of this study 
include the use of a national cohort including both sexes 
with a baseline age of 9–15 years and a follow-up period 
of over 30 years. Furthermore, measures of grip strength 
were available at three time points across the life course. 
This meant the BRLM could be used to address a research 
question that was, up to this point, unknown. Lastly, grip 
strength, a measure of overall muscular strength [26], is a 
reliable and valid field-based measure [29] and correlates 
with the one repetition maximum, a gold standard test to 
assess muscular strength [30].
5  Conclusion
Notwithstanding the limitations outlined, these findings sug-
gest that grip strength measured in childhood, young adult-
hood and mid-adulthood was equally associated with pre-
diabetes or type 2 diabetes highlighting the importance, and 
future cardiometabolic health benefits, of greater cumulative 
grip strength across the life course. Implementing strate-
gies aimed at increasing muscular strength in childhood 
and maintaining these behaviours into later life could help 
protect against the development of prediabetes and type 2 
diabetes.
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